OakChart

Viatris Inc

VTRSHealthcare·Drug Manufacturers - Specialty & Generic·USA·Large·NASD·Nov 11 • 3:59 PM ET

21.06+0.21 (1.01%)
2026-11-12 04:14 CET
Market cap
24,144.24 USD m
Revenue, TTM
14,739.40 USD m
Net income, TTM
-607.80 USD m
Free cash flow, TTM
2,110.40 USD m
EPS diluted, TTM
-0.53
P/E
-
Compare

Price

VTRS against its 20, 50 and 200-day averages
2050200miss
12.5015.0017.5020.0011.3M22.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26VTRSclose 21.0620-day 19.0450-day 17.96200-day 16.1621.06

0.2% under the 52-week high of 21.10 on 11 Nov 2026. 52-week low 10.15 on 21 Nov 2025. Last 15 sessions, 18.1% high to low

Volume 1.62× normal · the line is the 50-bar volume average

Profile

VTRS
52-week range, 100% of the way up
10.1520.86

Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

IndexS&P 500, RUI
Employees30000
IPOMar 17, 1980
Beta0.86
ATR, 14d0.57
Rel volume1.62
Short float3.14%
Insider own2.07%
Inst own95.31%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap24.14B
Enterprise Value35.82B
Income-607.80M
Sales14.74B
Book/sh11.94
Cash/sh1.66
Dividend Est.0.51 (2.40%)
Dividend TTM0.48 (2.28%)
Dividend Ex-DateNov 23, 2026
Dividend Gr. 3/5Y0.00% -
Payout-
Employees30000
IPOMar 17, 1980

Ratios

P/E-
Forward P/E7.66
PEG0.94
P/S1.64
P/B1.76
P/C12.69
P/FCF11.44
EV/EBITDA8.15
EV/Sales2.43
Quick Ratio0.88
Current Ratio1.46
Debt/Eq0.99
LT Debt/Eq0.86
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.53
EPS next Y2.75
EPS next Q0.61
EPS this Y9.14%
EPS next Y7.23%
EPS next 5Y8.16%
EPS past 3/5Y- -21.93%
Sales past 3/5Y-4.04% 3.66%
EPS Y/Y TTM82.97%
Sales Y/Y TTM4.80%
EPS Q/Q-157.22%
Sales Q/Q-0.28%
EarningsNov 05 BMO
EPS/Sales Surpr.11.51% -0.96%

Ownership

Insider Own2.07%
Insider Trans-0.21%
Inst Own95.31%
Inst Trans-0.21%
ROA-1.67%
ROE-4.21%
ROIC-2.39%
Gross Margin40.80%
Oper. Margin10.75%
Profit Margin-4.12%
SMA2010.60%
SMA5017.27%
SMA20030.28%
Trades-

Technical

Shs Outstand1.15B
Shs Float1.12B
Short Float3.14%
Short Ratio3.95
Short Interest35.24M
52W High20.86 0.96%
52W Low10.15 107.49%
Volatility4.19% 2.90%
ATR (14)0.57
RSI (14)75.42
Beta0.86
Rel Volume1.62
Avg Volume8.93M
Volume14,450,053

Performance

Perf Week9.57%
Perf Month22.09%
Perf Quarter31.30%
Perf Half Y21.24%
Perf YTD69.16%
Perf Year88.04%
Perf 3Y128.91%
Perf 5Y45.64%
Perf 10Y-44.48%
Recom2.21
Target Price21.33
Prev Close20.85
Price21.06
Change %1.01%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 23, 2026InitiatedOOppenheimerOutperform$25+18.7%
Sep 09, 2026InitiatedLLeerink PartnersOutperform$20-5.0%
Feb 09, 2026UpgradeUUBSNeutral → Buy$18-14.5%
Jan 16, 2026UpgradeAArgusHold → Buy$15-28.8%
Dec 09, 2025InitiatedBBarclaysOverweight$15-28.8%
Oct 15, 2025InitiatedTTruistBuy$15-28.8%
Jun 06, 2025InitiatedGGoldmanNeutral$10-52.5%
Jul 19, 2024ResumedJJefferiesBuy$15-28.8%
Oct 23, 2023DowngradeBBofA SecuritiesNeutral → Underperform$13 → $9-57.3%
Jun 23, 2023DowngradeBBarclaysEqual Weight → Underweight$11-47.8%

Peers

Mkt cap
TickerCompanyMkt cap
TEVATeva- Pharmaceutical Industries Ltd50.45B
AMRXAmneal Pharmaceuticals Inc7.56B
RDYDr. Reddy's Laboratories Ltd ADR12.36B
OGNOrganon & Co3.65B
ANIPANI Pharmaceuticals Inc1.63B
BHCBausch Health Companies Inc3.13B
TAKTakeda Pharmaceutical Co ADR66.58B
PRGOPerrigo Company plc2.30B
ALVOAlvotech1.92B
PFEPfizer Inc167.86B

Insider trading

latest 14 of 30
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Enrietti AndrewSee RemarksAug 15 '26Option Exercise0.0026,1330244,811Aug 18 06:01 PM
Campbell PaulSee RemarksJun 25 '26Sale16.1750,076809,784316,212Jun 26 05:00 PM
Paul CampbellOfficerJun 25 '26Proposed Sale16.1750,076809,678Jun 25 04:27 PM
Le Goff CorinneChief Commercial OfficerApr 15 '26Option Exercise0.0042,9880122,558Apr 16 06:00 PM
Campbell PaulSee RemarksMar 23 '26Sale13.2821,350283,539366,288Mar 24 06:04 PM
Paul CampbellOfficerMar 23 '26Proposed Sale13.2821,350283,508Mar 23 04:49 PM
Le Goff CorinneChief Commercial OfficerMar 06 '26Option Exercise0.0046,3580101,582Mar 10 07:04 PM
Mistras TheodoraChief Financial OfficerMar 06 '26Option Exercise0.0043,782092,787Mar 10 07:04 PM
SEVERINO MICHAELDirectorMar 06 '26Option Exercise0.0026,031026,031Mar 10 07:03 PM
PARRISH MARK WDirectorMar 06 '26Option Exercise0.0024,8350165,230Mar 10 07:03 PM
MARK RICHARD ADirectorMar 06 '26Option Exercise0.0024,8350116,145Mar 10 07:03 PM
Campbell PaulSee RemarksMar 06 '26Option Exercise0.0028,9740398,956Mar 10 07:03 PM
Smith Scott AndrewChief Executive OfficerMar 06 '26Option Exercise0.00130,70101,374,576Mar 10 07:03 PM
HIGGINS MELINA EDirectorMar 06 '26Option Exercise0.0024,8350146,048Mar 10 07:03 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
IVViShares Core S&P 500 ETFAUM: 871.38B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
RSPInvesco S&P 500 Equal Weight ETFAUM: 104.94B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B
IWRiShares Russell Mid-Cap ETFAUM: 58.68B
VYMVanguard High Dividend Yield Indx ETFAUM: 83.15B

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.7100.637-0.2803,7503,7869
2026Q22026-08-060.6900.601-0.1023,7573,6757
2026Q12026-05-070.5900.5020.1503,5173,3578
2025Q42026-02-260.5700.532-0.2953,7043,5327
2025Q32025-11-060.6700.621-0.1103,7603,6246
2025Q22025-08-070.6200.556-0.0043,5823,4675
2025Q12025-05-080.5000.492-2.5513,2543,2354
2024Q42025-02-270.5400.572-0.4333,5283,6006
2024Q32024-11-070.7500.6770.0793,7513,7156
2024Q22024-08-080.6900.679-0.2743,7973,7816
2024Q12024-05-090.6700.6730.0943,6633,6916
2023Q42024-02-280.6200.646-0.6383,8373,8876
2023Q32023-11-070.7890.7460.2753,9424,0018
2023Q22023-08-070.7520.7110.2193,9193,8617
2023Q12023-05-080.7740.6870.1863,7293,8018
2022Q42023-02-270.6740.7170.8283,8763,99011

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY4.4204.3120.03311,50111,530
2020FY4.0144.562-1.11411,97112,287
2021FY3.6963.715-1.05017,88617,889
2022FY3.3493.3951.70716,26316,372
2023FY2.9362.9630.04515,42715,473
2024FY2.6502.683-0.53214,73914,811
2025FY2.3502.317-3.00014,30014,128
2026FY-2.565--14,804
2027FY-2.750--15,365
2028FY-2.974--15,884
2029FY-2.990--16,094
2030FY-3.170--16,876

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-058213,7623,7113,802
2026Q4S2026-10-288013,7193,5963,797
2026Q4S2026-10-218013,7203,5963,800
2026Q4S2026-10-208023,7203,5963,800
2026Q4S2026-10-108043,7203,5963,800
2026Q4S2026-10-098053,7203,5963,800
2026Q4S2026-10-088053,7193,5963,800
2026Q4S2026-10-078053,7193,5963,800
2026Q4S2026-09-228053,7193,5963,800
2026Q4S2026-09-147053,7153,5963,800
2026Q4S2026-09-106043,7133,5963,800
2026Q4S2026-09-087043,7203,5963,800
2026Q4S2026-08-076043,7163,5963,800
2026Q4S2026-08-066033,7213,5963,800

Estimate history

EPS, annual1.30.6830.033-1.114-1.051.7070.045-0.532-3.002-0.5303
Period201720182019202020212022202320242025TTM
EPS, quarterly0.079-0.433-2.551-0.004-0.11-0.2950.15-0.102-0.283
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual11906.611427.711501.211941.217855.416173.515381.614709.714293.214739.4
Period201720182019202020212022202320242025TTM
Sales, quarterly3757.134763244.43581.437623705.43520.33762.23751.5
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual524.207515.799516.1491206.8961209.5071213.7931200.7551193.6481151.2151146.449
Period201720182019202020212022202320242025MRQ
Shares, quarterly1193.5811193.6481185.8171165.7131159.1621151.2151164.431155.2361146.449
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue14,739.4014,293.2014,709.7015,381.6016,173.5017,855.4011,941.2011,501.2011,427.70
Cost of Goods Sold Incl. D&A8,725.108,644.708,485.208,813.809,485.4011,659.407,924.707,314.607,087.00
Gross Profit6,014.305,648.506,224.506,567.806,688.106,196.004,016.504,186.604,340.70
Selling, General and Administrative Excl. Other4,430.004,486.004,363.704,514.704,179.004,528.603,899.703,203.503,097.50
Research and Development979.40952.50802.90793.00660.80737.80555.10639.90704.50
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income1,584.301,162.501,860.802,053.102,509.101,667.40116.80983.101,243.20
Interest Expense473.90478.20554.70574.90587.90631.90493.30510.20534.60
Unusual Expense1,657.204,447.201,591.701,275.901,065.501,693.00342.50284.20309.00
Net Income Before Taxes-526.40-3,665.00-623.20202.902,813.20-664.40-721.20154.40298.40
Income Taxes81.40-150.1011.00148.20734.60604.70-51.30137.60-54.10
Consolidated Net Income-607.80-3,514.90-634.2054.702,078.60-1,269.10-669.9016.80352.50
Net Income From Continuing Operations-607.80-3,514.90-634.2054.702,078.60-1,269.10-669.9016.80352.50
Net Income-607.80-3,514.90-634.2054.702,078.60-1,269.10-669.9016.80352.50
EPS (Recurring)0.48-0.340.400.792.32-0.07-0.720.421.10
EPS (Basic, Before Extraordinaries)-0.53-3.00-0.530.051.71-1.05-1.110.030.69
EPS (Diluted)-0.53-3.00-0.530.051.71-1.05-1.110.030.68
EBITDA4,396.703,886.904,569.304,732.305,363.204,879.102,012.302,821.903,353.10
Non-Operating Income (Expense)20.4097.90-337.600.601,957.50-6.90-2.20-34.30-101.20
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense139.04140.38115.42142.7591.9681.1857.8241.46-2.61
Price To Earnings Ratio---2.135.00--186.1111.90
Price To Sales Ratio1.381.021.010.850.840.920.940.901.24
Gross Margin40.8039.5242.3242.7041.3534.7033.6436.4037.98
Operating Margin10.758.1312.6513.3515.519.340.988.5510.88
Net Margin-4.12-24.59-4.310.3612.85-7.11-5.610.153.08
Shares Outstanding1,146.451,151.221,193.651,200.751,213.791,209.511,206.90516.15515.80
Market Capitalization24,144.2424,144.244,403.023,849.613,999.154,848.316,663.113,073.864,186.16

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue3,751.503,762.203,520.303,705.403,762.003,581.403,244.403,476.00
Cost of Goods Sold Incl. D&A2,187.802,185.102,139.202,213.002,375.002,174.802,029.402,162.40
Gross Profit1,563.701,577.101,381.101,492.401,387.001,406.601,215.001,313.60
Selling, General and Administrative Excl. Other1,090.801,100.201,034.301,204.701,069.601,046.901,038.001,158.30
Research and Development229.20245.20245.20259.80244.80216.00220.50205.40
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income472.90476.90346.80287.70317.40359.70177.00155.30
Interest Expense112.60119.80120.90120.60121.10118.80117.70122.50
Unusual Expense190.50485.90453.00527.80-34.60-1.302,955.80446.10
Net Income Before Taxes127.90-64.00-247.30-343.00-7.90-217.10-3,097.00-526.50
Income Taxes453.2054.80-423.70-2.90120.30-212.50-55.00-10.00
Consolidated Net Income-325.30-118.80176.40-340.10-128.20-4.60-3,042.00-516.50
Net Income From Continuing Operations-325.30-118.80176.40-340.10-128.20-4.60-3,042.00-516.50
Net Income-325.30-118.80176.40-340.10-128.20-4.60-3,042.00-516.50
EPS (Recurring)-0.170.190.420.03-0.13-0.00-0.82-0.17
EPS (Basic, Before Extraordinaries)-0.28-0.100.15-0.30-0.11-0.00-2.55-0.43
EPS (Diluted)-0.28-0.100.15-0.30-0.11-0.00-2.55-0.43
EBITDA1,170.101,149.201,022.901,054.501,005.901,038.00841.70901.50
Non-Operating Income (Expense)-41.9064.80-20.2017.70-238.80-459.30-200.50-113.20
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense31.2830.5738.0839.1028.4429.3143.6125.52
Price To Sales Ratio1.381.251.091.000.820.750.731.01
Gross Margin41.6841.9239.2340.2836.8739.2837.4537.79
Operating Margin12.6112.689.857.768.4410.045.464.47
Net Margin-8.67-3.165.01-9.18-3.41-0.13-93.76-14.86
Shares Outstanding1,146.451,155.241,164.431,151.221,159.161,165.711,185.821,193.65
Market Capitalization24,144.2418,638.0415,555.2814,339.5411,542.113,105.473,080.604,403.02

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments1,454.40829.601,079.901,337.80935.00934.90600.20480.60569.40
Short Term Receivables3,347.103,522.004,040.603,814.504,266.404,843.803,058.802,881.003,612.40
Inventories3,999.203,854.103,469.703,519.503,977.705,471.902,670.902,580.202,542.70
Other Current Assets420.20788.403,638.601,963.601,723.801,616.90427.40425.90488.80
Total Current Assets9,220.908,994.1012,228.8010,635.4010,902.9012,867.506,757.306,367.707,213.30
Net Property, Plant & Equipment2,885.302,919.203,005.203,283.803,479.403,783.502,404.202,170.202,339.10
Total Investments and Advances815.001,349.801,142.001,091.400.0047.9092.20138.70226.00
Intangible Assets21,856.8026,204.2029,048.2033,032.9038,247.9042,030.2021,240.5023,412.4025,451.50
Deferred Tax Assets1,061.20753.00692.90925.901,332.702,147.90703.10572.20496.80
Other Assets1,353.901,280.601,568.401,052.80879.90676.0058.2073.7079.60
Total Assets37,193.1041,500.9047,685.5050,022.2054,842.8061,553.0031,255.5032,734.9035,806.30
Short Term Debt Incl. Current Port. of LT Debt2,042.7095.402,026.401,339.703,457.203,502.301,534.30701.701,855.40
Accounts Payable1,293.701,355.301,381.401,158.001,056.101,345.701,061.901,617.001,452.50
Income Tax Payable124.00192.70226.80279.60236.90288.60213.00121.50112.90
Other Current Liabilities3,633.904,136.004,142.803,968.905,134.205,426.302,759.902,147.602,964.50
Total Current Liabilities7,094.305,779.407,777.406,746.209,884.4010,562.905,569.104,587.806,385.30
Long Term Debt12,658.7014,218.2016,353.5018,196.6019,918.0022,658.7011,390.0013,161.2012,865.30
Provision for Risks Charges542.20596.40563.50605.001,073.701,143.50408.90197.00285.90
Deferred Tax Liabilities892.001,107.901,735.702,432.002,815.003,123.701,627.501,722.002,012.40
Other Liabilities1,294.601,163.50788.00970.10659.001,110.10376.20899.80949.80
Total Liabilities22,481.8022,865.4027,218.1028,949.9034,350.1038,598.9019,371.7020,567.8022,498.70
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity14,711.3018,635.5020,467.4021,072.3020,492.7022,954.1011,883.8012,167.1013,307.60
Total Shareholders Equity14,711.3018,635.5020,467.4021,072.3020,492.7022,954.1011,883.8012,167.1013,307.60
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity14,711.3018,635.5020,467.4021,072.3020,492.7022,954.1011,883.8012,167.1013,307.60
Total Liabilities & Stockholders Equity37,193.1041,500.9047,685.5050,022.2054,842.8061,553.0031,255.5032,734.9035,806.30
Book Value Per Share12.7815.6117.0517.3616.9419.0223.0223.5925.39
Tangible Book Value Per Share-6.21-6.34-7.15-9.85-14.68-15.81-18.13-21.80-23.17
Full-Time Employees30,00032,00038,00037,00037,00045,00035,00035,00035,000
Price to Book Ratio1.760.220.190.210.240.290.260.340.51
Return on Assets-8.93-1.420.113.96-2.18-1.440.051.031.97
Return on Equity-21.08-3.240.2610.00-5.84-3.850.142.775.70
Return on Invested Capital-12.84-1.930.155.29-3.14-1.470.071.392.66
Quick Ratio0.740.891.131.050.700.700.730.830.73
Current Ratio1.301.561.571.581.101.221.211.391.13

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-607.80-3,514.90-634.2054.702,078.60-1,269.10-669.9016.80352.50
Depreciation2,738.502,724.402,708.502,679.202,854.103,211.702,216.101,838.802,109.90
Other Funds (Non Cash)1,037.404,269.301,314.801,164.10-1,031.602,203.40595.10648.50332.60
Funds from Operations2,683.703,002.302,621.503,510.903,875.204,821.701,928.102,311.502,530.70
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-198.40-686.40-318.60-711.30-922.60-1,804.80-696.30-507.80-189.00
Income Taxes Payable68.10-112.90219.30-76.7025.30-699.603.6057.90-23.90
Cash from Operating Activities2,485.302,315.902,302.902,799.602,952.603,016.901,231.801,803.702,341.70
Capital Expenditures-514.20-465.10-359.10-474.50-443.00-509.40-681.20-406.00-1,195.60
Net Assets From Acquisitions0.000.00-350.00-667.70-0.000.00-148.70-66.50
Sale of Fixed Assets and Businesses34.6037.402,509.80378.101,963.80392.00437.9028.0029.30
Purchase or Sale of Investments779.800.000.000.00-0.30-0.40-57.801.3021.80
Purchase of Investments-30.00-23.90-26.00-26.30-30.20-30.20-104.80-25.80-63.40
Sale Or Maturity of Investments809.8023.9026.0026.3029.9029.8047.0027.1085.20
Other Uses6.700.000.000.000.000.000.000.000.00
Other Sources0.000.00-0.000.000.00---
Cash from Investing Activities306.90-427.701,800.70-764.101,520.50-117.80-301.10-525.40-1,211.00
Cash Dividends Paid-555.10-561.20-574.80-575.60-581.60-399.000.000.000.00
Change in Capital Stock-382.80-497.90-247.50-246.903.300.000.608.10-414.20
Repurchase of Common Pref Stock-385.10-500.50-250.00-250.000.000.000.000.00-432.00
Sale of Common Pref Stock2.302.602.503.103.300.000.608.1017.80
Proceedsfrom Stock Options2.302.602.503.103.300.000.000.000.00
Issuance or Reduction of Debt, Net-928.500.10-3,713.70-1,250.10-3,282.00-2,106.10-403.30-1,105.90-653.10
Change in Long Term Debt-927.00-0.10-3,713.70-1,250.40-1,788.80-2,498.20-1,502.90-1,104.10-608.70
Issuance of Long Term Debt1,298.100.000.00-0.201,873.701,703.10981.304.402,556.50
Reduction of Long Term Debt-2,225.10-0.10-3,713.70-1,250.20-3,662.50-4,201.30-2,484.20-1,108.50-3,165.20
Net Financing Active Other Cash Flow-106.00-233.40210.40-229.30-17.60-506.90-203.00-71.20-23.00
Other Financing Activities Uses-106.00-233.40-84.80-229.30-17.60-506.90-203.00-71.20-23.00
Cash from Financing Activities-1,972.60-1,293.90-4,330.40-2,301.90-3,877.90-3,012.00-605.70-1,169.00-1,090.30
Exchange Rate Effect-30.4017.60-30.70-2.50-38.90-30.9033.80-7.50-21.00
Net Change in Cash789.20611.90-257.50-268.90556.30-143.80358.80101.8019.40
Free Cash Flow2,110.401,937.101,976.902,422.602,546.602,559.70988.801,590.502,089.60
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow13.0910.5910.607.086.907.5711.396.536.77
Deferred Taxes & Investment Tax Credit--476.50-767.60-387.10-25.90675.70-213.20-192.60-264.30

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments1,902.601,409.802,260.901,454.401,107.90667.60
Short Term Receivables3,420.103,669.503,742.003,347.103,587.203,597.30
Inventories3,829.203,933.203,927.003,999.204,111.404,264.30
Other Current Assets529.60432.40422.90420.20486.50580.30
Total Current Assets9,681.509,444.9010,352.809,220.909,293.009,109.50
Net Property, Plant & Equipment2,671.202,698.802,780.902,885.302,892.102,918.90
Total Investments and Advances0.000.00115.80815.00850.00950.00
Intangible Assets19,699.5020,331.3021,174.7021,856.8022,453.7023,072.10
Deferred Tax Assets1,173.001,157.701,109.201,061.20999.00924.30
Other Assets1,457.401,411.901,301.201,353.901,432.601,436.70
Total Assets34,682.6035,044.6036,834.6037,193.1037,920.4038,411.50
Short Term Debt Incl. Current Port. of LT Debt1,841.001,854.202,032.802,042.702,063.801,792.30
Accounts Payable1,653.301,726.501,199.801,293.701,326.401,320.00
Income Tax Payable120.000.000.00124.000.000.00
Other Current Liabilities3,022.202,765.103,577.703,633.903,973.904,021.10
Total Current Liabilities6,636.506,345.806,810.307,094.307,364.107,133.40
Long Term Debt11,741.0011,772.2012,580.7012,658.7012,659.0012,973.60
Provision for Risks Charges562.30566.00587.90542.20608.80617.50
Deferred Tax Liabilities776.00802.80870.60892.001,028.201,080.80
Other Liabilities1,281.301,297.401,327.401,294.601,042.701,035.70
Total Liabilities20,997.1020,784.2022,176.9022,481.8022,702.8022,841.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity13,685.5014,260.4014,657.7014,711.3015,217.6015,570.50
Total Shareholders Equity13,685.5014,260.4014,657.7014,711.3015,217.6015,570.50
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity13,685.5014,260.4014,657.7014,711.3015,217.6015,570.50
Total Liabilities & Stockholders Equity34,682.6035,044.6036,834.6037,193.1037,920.4038,411.50
Book Value Per Share11.9412.3412.5912.7813.1313.36
Tangible Book Value Per Share-5.25-5.26-5.60-6.21-6.24-6.44
Full-Time Employees---30,00030,000-
Price to Book Ratio1.761.261.060.950.740.20
Return on Assets-1.67-1.12-0.79-8.93-8.93-8.28
Return on Equity-4.21-2.75-1.96-21.08-21.09-19.77
Return on Invested Capital-1.28-0.460.65-1.24-0.46-0.02
Quick Ratio0.880.870.940.740.700.68
Current Ratio1.461.491.521.301.261.28

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-325.30-118.80176.40-340.10-128.20-4.60
Depreciation697.20672.30676.10692.90688.50678.30
Other Funds (Non Cash)109.50300.10308.40319.40195.80575.80
Funds from Operations439.40729.101,091.20424.00618.901,202.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital460.00-347.30-702.90391.80126.00-982.30
Income Taxes Payable365.1040.90-463.40125.50128.20-246.00
Cash from Operating Activities899.40381.80388.30815.80744.90219.70
Capital Expenditures-88.60-53.80-121.90-249.90-99.70-54.10
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses1.108.201.6023.700.801.60
Purchase or Sale of Investments379.800.00400.000.000.000.00
Purchase of Investments-7.40-9.30-7.50-5.80-7.20-6.30
Sale Or Maturity of Investments387.209.30407.505.807.206.30
Other Uses0.00-6.00-2.3015.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities292.30-51.60277.40-211.20-98.90-52.50
Cash Dividends Paid-137.50-139.80-139.60-138.20-139.90-139.80
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-149.50-149.300.50-84.50-64.30-174.30
Repurchase of Common Pref Stock-150.00-150.000.00-85.10-65.00-175.00
Sale of Common Pref Stock0.500.700.500.600.700.70
Proceedsfrom Stock Options0.500.700.500.600.700.70
Issuance or Reduction of Debt, Net-1.70-925.200.00-1.600.300.00
Change in Long Term Debt-1.70-925.200.00-0.100.000.00
Issuance of Long Term Debt-1.701,299.800.000.000.000.00
Reduction of Long Term Debt0.00-2,225.000.00-0.100.000.00
Net Financing Active Other Cash Flow-1.10-28.30-64.70-11.90-23.90-47.30
Other Financing Activities Uses-1.10-28.30-64.70-11.90-23.90-47.30
Cash from Financing Activities-289.80-1,242.60-203.80-236.40-228.10-362.40
Exchange Rate Effect0.80-3.30-4.20-23.7017.806.70
Net Change in Cash902.70-915.70457.70344.50435.70-188.50
Free Cash Flow813.70329.00348.40619.30658.10166.80
Price to Free Cash Flow13.0913.2212.8610.4310.548.86

Revenue breakdown

Brands2024: 9.20B 2025: 9.18B
Consolidation, Policy2024: 46.50M 2025: 49.50M
Generics2024: 5.49B 2025: 5.07B
United States2024: 14.74B 2025: 14.30B
China2024: 2.17B 2025: 2.33B
Consolidation, Policy2024: 46.50M 2025: 49.50M
Developed Markets2024: 8.93B 2025: 8.51B
Emerging Markets2024: 2.25B 2025: 2.21B
Japan, Australia and New Zealand2024: 1.35B 2025: 1.19B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.14%35.2M1122.8M9.21M
2026-10-153.37%37.9M1124.9M9.26M
2026-09-303.74%42.0M1124.9M9.41M
2026-09-153.63%40.8M1124.9M9.52M
2026-08-313.43%38.6M1124.9M9.77M
2026-08-143.29%37.0M1125.4M10.32M
2026-07-313.97%45.7M1150.0M10.88M
2026-07-154.11%47.2M1150.0M11.15M
2026-06-304.18%48.0M1149.8M10.86M
2026-06-153.95%45.1M1140.2M10.67M
2026-05-293.60%41.1M1140.8M11.11M
2026-05-153.34%38.1M1140.8M11.34M
2026-04-303.31%37.8M1140.2M10.62M
2026-04-153.09%35.2M1140.2M9.99M
2026-03-312.85%32.1M1127.7M10.34M
2026-03-132.51%28.3M1127.7M10.20M
2026-02-272.51%28.3M1127.7M9.42M
2026-02-132.34%26.5M1128.1M8.82M
2026-01-302.48%27.8M1124.4M8.84M
2026-01-152.25%25.3M1124.4M8.72M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call9.0011.2012.900.005.3020.000.000.986-0.0170.001
call10.0010.2011.9010.804.7522.001.000.984-0.0170.001
call11.009.1010.900.004.2600.000.000.982-0.0170.001
call12.008.309.908.803.8124.001.000.980-0.0170.002
call13.007.108.904.383.4003.000.000.977-0.0160.002
call14.006.107.900.003.0170.000.000.974-0.0160.002
call15.005.306.905.912.6566.003.000.969-0.0160.002
call16.004.405.904.912.31442.0011.000.964-0.0150.003
call17.003.604.703.921.75898.0011.000.957-0.0150.003
call18.002.953.202.960.8296086.000.946-0.0140.004
call19.001.952.202.050.6111,04911.000.927-0.0130.005
call20.001.101.351.250.5414,5731210.786-0.0240.010
call21.000.300.550.450.3954,06777.000.532-0.0340.013
call22.000.050.300.110.35866119.000.295-0.0310.011
call23.000.000.250.000.4020.000.000.102-0.0140.006
call24.000.000.050.050.5461120.000.064-0.0120.004
call25.000.000.050.000.6660.000.000.054-0.0130.004
call26.000.000.250.000.7870.000.000.049-0.0150.003
call27.000.000.250.000.8970.000.000.044-0.0150.003
put9.000.000.250.002.7440.000.00-0.014-0.0180.001
put10.000.000.100.002.4330.000.00-0.015-0.0180.001
put11.000.000.250.002.1520.000.00-0.017-0.0170.001
put12.000.000.250.051.8941.000.00-0.020-0.0170.002
put13.000.000.250.101.6561.000.00-0.023-0.0160.002
put14.000.000.250.011.4331.000.00-0.026-0.0160.002
put15.000.000.250.051.2242900.00-0.030-0.0150.002
put16.000.000.300.031.0257500.00-0.035-0.0150.003
put17.000.000.100.030.8341,8582.00-0.043-0.0140.003
put18.000.000.100.050.6483,3170.00-0.054-0.0130.004
put19.000.000.250.080.46624215.00-0.072-0.0120.005
put20.000.050.150.100.40710712.00-0.213-0.0240.010
put21.000.150.650.000.5240.000.00-0.467-0.0340.013
put22.000.951.600.000.8030.000.00-0.705-0.0300.011
put23.001.152.700.001.1350.000.00-0.898-0.0130.006
put24.002.103.800.001.4400.000.00-0.933-0.0120.004
put25.003.105.000.001.8120.000.00-0.944-0.0130.004
put26.004.106.000.001.9980.000.00-0.951-0.0130.003
put27.005.107.000.002.1700.000.00-0.956-0.0140.003

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-06SCHEDULE 13G/ASEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-10-30SC TO-TThird party tender offer statementSEC
2026-10-08SC TO-CWritten communication relating to an issuer or third party tender offerSEC
2026-10-08SC TO-CWritten communication relating to an issuer or third party tender offerSEC
2026-10-088-KCurrent report2026-10-08SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-08SCHEDULE 13G/ASEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-12SCHEDULE 13G/ASEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-08-06SCHEDULE 13GSEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-018-KCurrent report2026-07-01SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-25SEC
2026-06-25144Filing for proposed sale of securities under Rule 144.SEC
2026-06-188-KCurrent report2026-06-17SEC
2026-06-158-KCurrent report2026-06-12SEC
2026-06-15424B5SEC
2026-06-12FWPFiling under Securities Act Rule 163/433 of free writing prospectuses.SEC
2026-06-12424B5SEC
2026-05-158-KCurrent report2026-05-15SEC
2026-05-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-078-KCurrent report2026-05-07SEC
2026-05-05SCHEDULE 13G/ASEC
2026-05-048-KCurrent report2026-05-01SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-0600809.78K1
2026-050000
2026-040000
2026-0300283.54K1
2026-020000
2026-010000
2025-120000
2025-112.22K100

Institutional holders

Manager% owned
FMR LLC11.63%
BlackRock, Inc.7.33%
VANGUARD CAPITAL MANAGEMENT LLC6.48%
DAVIS SELECTED ADVISERS6.30%
PRICE T ROWE ASSOCIATES INC /MD/5.81%
VANGUARD PORTFOLIO MANAGEMENT LLC4.62%
STATE STREET CORP4.52%
Rubric Capital Management LP2.91%
GEODE CAPITAL MANAGEMENT, LLC2.88%
Invesco Ltd.1.77%

Funds

Fund% owned
Baird Ultra Short Bond Fund5.69%
PGIM Total Return Bond Fund4.38%
Franklin Income Fund3.41%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.15%
VANGUARD 500 INDEX FUND2.57%
VANGUARD SMALL-CAP INDEX FUND2.28%
PGIM Short-Term Corporate Bond Fund2.25%
Bond Fund1.98%
Strategic Advisers Fidelity U.S. Total Stock Fund1.93%
Baird Core Plus Bond Fund1.87%

OakChart. VTRS. Cached 15 minutes.